The Nestlé Health Science Vision
"Pioneering science-based nutritional solutions to deliver improved
personalised health care for medical conditions"
Nestlé Health Science is an innovative company driven by a pioneering vision. By creating a new model between the traditional food and pharma industries, it aims to shape a different approach to disease prevention and treatment designed for the modern age. Personalised health science nutrition has the opportunity to offer a compelling and cost effective solution to many of today’s chronic and acute medical conditions and diseases, among them diabetes, Alzheimer’s, obesity and arteriosclerosis. These conditions and others, are placing an unsustainable burden, in care and cost, on healthcare systems, systems which are based on treating sick people rather than preventing illness. The Nestlé Health Science vision encompasses a scientific base for personalised health science nutrition through developing deeper understanding of disease processes to inform and design nutrition plans and products. Through acquisitions such as Vitaflo, it extends to developing the first of many nutritional products tailored for those with specific genetic conditions. The Nestlé Health Science vision also aims to support society by delivering a positive impact on peoples’ lives.
A message from our CEO
Luis Cantarell, President and CEO of Nestlé Health Science, talks about the vision of the newly formed company. Learn more
Applying health science
Health science nutrition's aim is to have a better understanding of how our body functions, in order to improve health through nutrition. Learn more
Vitaflo: Breaking new ground
This company is one example of personalised nutrition intervention with products being tailored to people with specific genetic conditions. Learn more
The economics of health
There is a growing concern regarding the need to address increasing health care budgets. Through personalised, innovative, nutritional solutions, Nestlé Health Science will contribute to the resolution of this issue. Learn more